nab-Sirolimus for patients with advanced malignant PEComa with or without prior mTOR inhibitors: Biomarker results from AMPECT and an expanded access program.

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Dickson, MA; Ravi, V; Riedel, RF; Ganjoo, KN; Van Tine, BA; Chugh, R; Cranmer, LD; Gordon, EM; Chen, JL; Murphy, MC; Schmid, AN; Desai, N; Palma, NA; Kwiatkowski, DJ; Wagner, AJ

Published Date

  • 2022

Published In

Volume / Issue

  • 40 / 16

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X